Shockwave Reducer at EuroPCR 2024: Reducer Implant Step by Step
Check out this clip from our latest EuroPCR 2024 symposium to hear from Prof. Stefan Verheye, Prof. Tommaso Gori, Dr. Hakim Benamer, Prof. James Spratt and Martine Gilard as they discuss the role of Shockwave Reducer in treating patients suffering from refractory angina.
The physicians featured are paid consultants for Shockwave Medical.
*Shockwave Reducer is CE-marked in Europe and has been implanted in over 3,500 patients. It is currently under clinical investigation in the US.
CAUTION: In the United States, the Shockwave Reducer is an investigational device, limited by United States law to investigational use. The Reducer is subject of Investigational testing and is being studied in the COSIRA-II trial in Canada. The Reducer is commercially available in certain countries outside the U.S. and Canada. Please contact your local representative for specific country availability. Prior to use, please reference the Instructions for Use for more information on warnings, precautions and adverse events: ifu.neovasc.com
